ScienceDex / Researcher record
Parhami, Farhad
- Max Biopharma, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Long-Funded
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2006 | $331,912 | 1 | #18,784 |
| 2007 | $322,287 | 1 | #21,680 |
| 2008 | $315,841 | 1 | #22,261 |
| 2009 | $315,841 | 1 | #26,376 |
| 2011 | $346,500 | 1 | #22,254 |
| 2012 | $346,500 | 1 | #22,563 |
| 2013 | $329,175 | 1 | #22,833 |
| 2014 | $339,570 | 1 | #22,871 |
| 2015 | $346,500 | 1 | #22,790 |
| 2021 | $855,153 | 1 | #11,245 |
| 2022 | $1,491,200 | 3 | #5,690 |
| 2023 | $896,990 | 1 | #11,689 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20061 record
- FY20071 record
- FY20081 record
- FY20091 record
- FY20111 record
- FY20121 record
- FY20131 record
- FY20141 record
- FY20151 record
- FY20211 record
- FY20223 records
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Parhami, Farhad as a PI. Multi-PI records show the full award amount for context.
- 1R44DK136405-01R44Contact PIEvaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis$897Kaward amount
Award organization
Organizations that administered FY2023 awards listing Parhami, Farhad as a PI.
FY2023 award administered by Max Biopharma, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardMax Biopharma, Inc.
- 2007$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2013$2M Cumulative Funding
- 2022$5M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5690